Hyperammonaemia is a key factor in the pathogenesis of hepatic encephalopathy (HE) as well as other metabolic encephalopathies such as those associated with inherited disorders of urea cycle enzymes and in Reye's syndrome. Acute HE results in increased brain ammonia (up to 5mM), astrocytic swelling and altered glutamatergic function. In the present study, by guest on
Summary
Hyperammonaemia is a key factor in the pathogenesis of hepatic encephalopathy (HE) as well as other metabolic encephalopathies such as those associated with inherited disorders of urea cycle enzymes and in Reye's syndrome. Acute HE results in increased brain ammonia (up to 5mM), astrocytic swelling and altered glutamatergic function. In the present study, using fluorescence imaging techniques, acute exposure (10 minutes) of ammonia (NH 4 + /NH 3 ) to cultured astrocytes resulted in a concentration-dependent, transient increase in [Ca 2+ ] i . This calcium transient was due to release from intracellular calcium stores since the response was thapsigargin-sensitive and was still observed in calcium-free buffer. Using an enzyme-linked fluorescence assay, glutamate release was measured indirectly via the production of NADH (a naturally fluorescent product when excited with UV light). 
Introduction
Hyperammonemia consequently leads to increased concentrations of ammonia, up to 5mM, in the brain. This high level of brain ammonia is a key factor in the pathogenesis of central nervous system (CNS) dysfunction in acute and chronic liver failure. The nature and severity of the CNS disorder mainly depends upon the degree and acuteness of the onset of hyperammonemia (1) . Acute liver failure (ALF) resulting from viral infections or toxic liver injury is a life-threatening condition where hepatic encephalopathy (HE) develops rapidly and mortality rates are high due to brainstem herniation caused by increased intracranial pressure; a fatal consequence of cytotoxic brain edema. Excess ammonia is toxic to the brain resulting in deleterious effects, by both direct and indirect mechanisms, on cerebral metabolism and neurotransmission.
Over the past 10 years, there has been an increasing body of evidence demonstrating that ammonia toxicity is involved in alterations of glutamatergic synaptic regulation which is implicated in the pathophysiology of HE in ALF. Several reports have consistently described increased extracellular concentrations of brain glutamate in different models of experimental ALF (2-5) however neither the cell type nor the underlying release mechanisms have been identified. One possible explanation for the increased extracellular glutamate may be ammonia's inhibitory effects on the glutamate transporter system in astrocytes. It has been shown that ammonia inhibits glutamate uptake into astrocytes in vitro (6) and decreased protein and gene expression of the glutamate transporter GLT-1 (EAAT-2) in frontal cortex of rats with ALF (7). Ammonia's role in the glutamatergic dysfunction demonstrated in HE is supported with a positive correlation between extracellular brain concentrations of glutamate and arterial ammonia concentrations in ALF in rats (4) . In addition, using mild hypothermia as a treatment in rats with ALF, extracellular brain glutamate concentrations were normalized concomitantly with a lowering of brain ammonia (8) .
Glutamate has been demonstrated to be an important signalling molecule for neuronglia communication. Astrocytes express receptors and transporters for glutamate, and recently have also been demonstrated to contain the protein machinery necessary to release glutamate by exocytosis through vesicles (9,10) and a fusion-related mechanism (11, 12) . Overall, astrocytes have many characteristics which were previously considered exclusive for neurons and are therefore actively involved in cell signalling by releasing glutamate. Astrocytic glutamate release is calcium-dependent and can be triggered by any ligand which stimulates an increase in [Ca 2+ ] i , such as bradykinins (13) , prostaglandins (14) and ATP (15, 16) . Even a spontaneous [Ca 2+ ] i increase leads to glutamate release from astrocytes (17).
A rapid increase in ammonia results in an increase in [pH] i (intracellular alkanization) in all cell types including astrocytes (18) . It has been also demonstrated that intracellular alkalinization is accompanied with an increase in [Ca 2+ ] i in cultured acinar cells (19) , in enthothelial cells (20) in pituitary cells (21) and in neurons (22 
Solutions
All solutions were freshly prepared from refrigerated stock solutions. The standard bath solution was composed of (in mM): NaCl, 150; KCl, 5.4; CaCl 2 , 2; MgCl 2 , 1; HEPES, 7 with a pH of 7.4. When GPT (~23U/mL) and alanine (1mM) were added, adjustments with glucose were made to correct for osmolarity measured by a freezing-point osmometer (model 5002, Precision Intruments, Natick, MA).
All the experiments were performed at room temperature (20-23 o C) using confluent astrocytic cultures.
To estimate the extracellular levels of glutamate, known concentrations of glutamate were applied by pipette using cell-free buffer in the presence of GDH (or GDH + GPT), NAD + and alanine. The flow of the solution was stopped to allow NADH to accumulate in a concentration-and time-dependent manner. With GDH alone, the amplitude of the fluorescent signal reached a peak after 20-30 seconds and sustained. With GDH+GPT, the amplitude of the fluorescent signal never reached a plateau and therefore to be able to compare both assays, fluorescence was measured after 10 minutes for all experiments. The approximate concentration of glutamate released from cells was estimated from the respective standard curves.
Data are expressed as NADH formation (% baseline) where baseline represents the fluorescence level of the optical field before cell stimulation; sum of fluorescence emitted from GDH + NAD + along with basal NADH (either as a contaminant or because of enzymatic activity). Data was collected from at least 3 different cultures.
Measurement of intracellular calcium
Cultured astrocytes on coverslips were incubated with 5µM fura-2/acetoxymethylester (AM) for 20 minutes in physiological buffer in the dark at room temperature. Cells were then washed with physiological buffer and stored in the dark for an additional 20 minutes to ensure fura-2/AM hydrolysis. Coverslips with loaded cells were transferred to the perfusion chamber and visualized under the microscope. Fura-2, a ratiometric dye, was excited with UV light at 340 and 380nm and the emission was measured at 530 ± 10nm. ] i =K d β(R-R min )/(R max -R); where R = F 340 /F 380 , R min is the fluorescent ratio of calciumfree:fura-2 and R max is the ratio of calcium-bound:fura-2. The constant K d β was determined empirically. The system was calibrated in situ by employing an ionomycin-based intracellular calibration procedure as described previously (27) . The parameters K d β, R min and R max characterising the system were 1.6µM, 0.2 and 2.1, respectively. Glutamate released from cultured astrocytes has previously been recorded using an enzyme-linked fluorescence assay (14, 15, 32 (Fig. 6A) . At 5µM glutamate, NADH formation was barely detectable.
Measurement of intracellular pH
To increase the sensitivity to detect NADH, an enzymatic loop was produced to amplify the NADH production. This was accomplished by adding a second enzyme GPT and alanine ( Fig. 6 (insert) ; reaction 2).
To demonstrate the difference between a non-amplified (GDH only) and an amplified (GDH+GPT) response, typical traces are shown in Fig. 6B application to cultured astrocytes resulted in an increase in NADH formation as a measure of glutamate release. In physiological buffer, the basal NADH formation within the 10 minute recording period was 9.3 ± 1.5% (n=19 coverslips). In the presence of NH 4 + /NH 3 (5mM) it was significantly higher (23.7 ± 2.5%, n=26 coverslips, p<0.01). NADH formation occurred with a small delay after application of NH 4 + /NH 3 (5mM). We assume that, in the beginning, NADH levels are too low to be detected by our system, but with further amplification NADH levels surpassed the threshold of our detection system ( (5mM) it amounted to 23.2 ± 2.6% (n=22 coverslips) (Fig. 7B ) and 45.0 ± 6.6% (n=16 coverslips) (Fig. 8B) (Fig. 8B) . Cell swelling-induced glutamate release has been demonstrated in cortical astrocytes exposed to a hypo-osmotic medium (37) . Since astrocytic swelling is a pathological characteristic observed in acute HE, it was important to test whether glutamate release was due to cell swelling. In our study, using the isobestic point of fura-2, (where the probe is Ca (5mM) stimulated glutamate release was a result of cell swelling, glutamate release would have persisted when astrocytes were pre-treated with BAPTA/AM, which was not the case.
Therefore, the ammonia-induced glutamate release is not due to cell swelling. In support, Albrecht's group has shown that a 10 minute treatment with 5mM ammonia did not produce cell swelling in cultured rabbit Muller cells (38) 
